ATE275630T1 - Fas ligand ähnliches protein, seine herstellung und verwendung - Google Patents

Fas ligand ähnliches protein, seine herstellung und verwendung

Info

Publication number
ATE275630T1
ATE275630T1 AT97930820T AT97930820T ATE275630T1 AT E275630 T1 ATE275630 T1 AT E275630T1 AT 97930820 T AT97930820 T AT 97930820T AT 97930820 T AT97930820 T AT 97930820T AT E275630 T1 ATE275630 T1 AT E275630T1
Authority
AT
Austria
Prior art keywords
protein
salt
partial peptide
fas ligand
antibody
Prior art date
Application number
AT97930820T
Other languages
English (en)
Inventor
Kazunori Nishi
Yukiko Hikichi
Yasushi Shintani
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE275630T1 publication Critical patent/ATE275630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT97930820T 1996-07-19 1997-07-17 Fas ligand ähnliches protein, seine herstellung und verwendung ATE275630T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP19120496 1996-07-19
JP21169596 1996-08-09
JP1933097 1997-01-31
PCT/JP1997/002480 WO1998003648A1 (en) 1996-07-19 1997-07-17 Fas ligand-like protein, its production and use

Publications (1)

Publication Number Publication Date
ATE275630T1 true ATE275630T1 (de) 2004-09-15

Family

ID=27282588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930820T ATE275630T1 (de) 1996-07-19 1997-07-17 Fas ligand ähnliches protein, seine herstellung und verwendung

Country Status (7)

Country Link
US (2) US6235878B1 (de)
EP (1) EP0922099B1 (de)
AT (1) ATE275630T1 (de)
AU (1) AU3461797A (de)
CA (1) CA2260767A1 (de)
DE (1) DE69730607T2 (de)
WO (1) WO1998003648A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
CA2248868A1 (en) * 1996-03-22 1997-09-25 Human Genome Sciences, Inc. Apoptosis inducing molecule ii
US6495520B2 (en) 1996-03-22 2002-12-17 Human Genome Sciences, Inc. Apoptosis Inducing Molecule II and methods of use
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US6479254B2 (en) * 1996-03-22 2002-11-12 Human Genome Sciences, Inc. Apoptosis inducing molecule II
ATE275630T1 (de) * 1996-07-19 2004-09-15 Takeda Chemical Industries Ltd Fas ligand ähnliches protein, seine herstellung und verwendung
US6998108B1 (en) 1997-07-07 2006-02-14 La Jolla Institute For Allergy And Immunology Antibodies to p30 polypeptides and methods making and using same
US6140467A (en) * 1997-07-07 2000-10-31 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US7118742B2 (en) 1997-07-07 2006-10-10 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
CA2321186A1 (en) * 1998-02-20 1999-08-26 Human Genome Sciences, Inc. Apoptosis inducing molecule ii and methods of use
WO2000024427A1 (en) * 1998-10-28 2000-05-04 St. Marianna University School Of Medicine Remedies for rheumatism containing fadd gene as the active ingredient
WO2000053223A1 (en) * 1999-03-11 2000-09-14 Human Genome Sciences, Inc. Apoptosis inducing molecule ii and methods of use
CA2374273A1 (en) * 1999-05-21 2000-11-30 Takeda Chemical Industries, Ltd. Liver function controlling agents
WO2001079496A2 (en) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
AU2001244647A1 (en) * 2000-03-30 2001-10-15 Takeda Chemical Industries Ltd. Process for producing recombinant protein
DK1674575T3 (da) * 2000-04-12 2010-11-29 Jolla Inst Allergy Immunolog Ligand for Herpes simplex-indgangsmediator og fremgangsmåder til anvendelse
WO2002066049A1 (fr) * 2001-02-23 2002-08-29 Takeda Chemical Industries, Ltd. Agents pour changement plasmique
EP1364653A4 (de) * 2001-02-23 2005-01-26 Takeda Pharmaceutical Casoase-3-hemmer
WO2003027242A2 (en) * 2001-09-24 2003-04-03 Duke University Fas ligand
JP4429726B2 (ja) * 2002-02-08 2010-03-10 ワイス 炎症性応答を調節するための組成物および方法
AU2003234706A1 (en) * 2002-04-15 2003-11-03 Human Genome Sciences, Inc. Antibodies that specifically bind to tl5
JP5209625B2 (ja) 2006-08-28 2013-06-12 協和発酵キリン株式会社 アンタゴニストのヒトｌｉｇｈｔ特異的ヒトモノクローナル抗体
WO2008051612A2 (en) * 2006-10-25 2008-05-02 La Jolla Institute For Allergy And Immunology Light-mediated anti-cell proliferative compositions and methods
US20100004238A1 (en) 2006-12-12 2010-01-07 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US20090093429A1 (en) * 2007-02-08 2009-04-09 Yang-Xin Fu Combination therapy for treating cancer
TW200944528A (en) 2008-03-12 2009-11-01 Takeda Pharmaceutical Fused heterocyclic compound
MX2011004467A (es) * 2008-10-31 2011-07-28 Biogen Idec Inc Moleculas de objetivo light y usos de las mismas.
PH12015502097B1 (en) 2013-03-13 2023-02-03 Forma Therapeutics Inc Novel compounds and compositions for inhibition of fasn
CN111183222B (zh) * 2017-07-05 2023-12-12 奥利希罗基因组学有限公司 Dna的产生方法及dna片段连接用试剂盒
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127594A (ja) 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
US5663070A (en) 1993-11-15 1997-09-02 Lxr Biotechnology Inc. Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
WO1995018819A1 (en) * 1994-01-07 1995-07-13 Immunex Corporation Ligand that binds fas antigen
US5759536A (en) 1994-05-27 1998-06-02 University Technology Corporation Use of fas ligand to supress T-lymphocyte-mediated immune responses
WO1997033899A1 (en) 1996-03-14 1997-09-18 Human Genome Sciences, Inc. Apoptosis inducing molecule i
CN1214050A (zh) 1996-03-14 1999-04-14 人体基因组科学有限公司 人肿瘤坏死因子δ和ε
CA2248868A1 (en) 1996-03-22 1997-09-25 Human Genome Sciences, Inc. Apoptosis inducing molecule ii
ATE275630T1 (de) * 1996-07-19 2004-09-15 Takeda Chemical Industries Ltd Fas ligand ähnliches protein, seine herstellung und verwendung

Also Published As

Publication number Publication date
US6235878B1 (en) 2001-05-22
EP0922099A1 (de) 1999-06-16
WO1998003648A1 (en) 1998-01-29
CA2260767A1 (en) 1998-01-29
DE69730607T2 (de) 2005-01-27
AU3461797A (en) 1998-02-10
EP0922099B1 (de) 2004-09-08
US6590090B1 (en) 2003-07-08
DE69730607D1 (de) 2004-10-14

Similar Documents

Publication Publication Date Title
ATE275630T1 (de) Fas ligand ähnliches protein, seine herstellung und verwendung
CA2380690A1 (en) Human osteoclast-derived cathepsin
DE69929310D1 (de) Tumorassoziierte antigenderivate der mage-familie, nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
GEP20033002B (en) Osteoprotegerin Binding Protein and Receptors
EP1067182A8 (de) Sekretorische- oder Membranproteine
FI900808A0 (fi) Humant mannos bindande protein.
HUP0103758A2 (hu) Neurotróf faktorok
MXPA04004609A (es) Composicion que comprende y metodo para utilizar angptl3 de proteina 3 como angiopoyetina.
NZ500253A (en) Osteoprotegerin binding proteins and receptors
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE60027409D1 (de) Glykosylierte leptinzusammensetzungen und zugehörige verfahren
WO2000015659A3 (en) Stomach polypeptide zsig28
DE69736158D1 (de) Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
DE69836626D1 (de) Proteine mit lecithin-cholesterin acetyltransferase-ähnlicher aktivität, deren herstellung und verwendung
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
DK0833948T3 (da) Tyktarmspecifikt gen og protein
SE9002212D0 (sv) Igg binding protein
ATE302214T1 (de) Enamel-matrix bezogene polypeptide
WO1999055885A3 (en) Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
DE3876227D1 (de) Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung.
WO2000007545A8 (en) Apoptosis proteins
DE69025761D1 (de) Verfahren zur erhöhung der rate der modifikation metastabiler bindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties